September 9th 2025
Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit
August 6th 2025
Can AI compete with the well-oiled machine of the contemporary clinic?
July 23rd 2025
The nitric oxide-donating bimatoprost therapy is intended to lower intraocular pressure in patients with glaucoma or ocular hypertension
July 9th 2025
Phil Lai, MD, chief medical officer of Perfuse Therapeutics, said the company's goal is to pioneer disease-modifying treatment that targets an underlying pathology of ischemia
June 24th 2025
The framework covers ocular hypertension to severe progression
Excimer laser trabeculotomy
The article looks at a minimally invasive glaucoma laser procedure with a long-lasting IOP lowering efficiency.
Foldable IOL for glaucoma requires long-term follow-up
Long-term follow-up is necessary in secondary pigmentary glaucoma patients implanted with a foldable IOL in the ciliary sulcus, advises a recent journal paper.
GMS+ implantation not effective for IOP control
Gold Micro Shunt Plus (GMS+) implantation is not an effective method for controlling IOP in glaucoma patients, according to a recent study in the journal BMC Ophthalmology.
Options for treating advanced glaucoma
In this article, Prof. Bron discusses treatment considerations, advocating the treatment of the whole patient.
Combating compliance issues by reducing dependence
Here, Dr Noecker discusses options that are available to patients, highlighting the MIGS procedures, which he believes offer promise to reign in compliance issues in glaucoma care.
IOP reduction in OAG
Prof. Auffarth reveals data that suggests the iStent supra is capable of significantly reducing IOP.
PGA-timolol combo effective for POAG
A combination of prostaglandin analog (PGA) and timolol 0.1 & gel reduces both IOP and fluctuations in primary-angle glaucoma patients, states a recent paper in European Journal of Ophthalmology.
GAT influences CCT
Goldmann applanation tonometry is affected by central corneal thickness, reveals a study in the Journal of Glaucoma.
Glaucoma device controls IOP in high-risk PK
The Ahmed glaucoma device (AGD) effectively controls intraocular pressure (IOP) with high-risk penetrating keratoplasty, reveal the findings from a study in the journal Cornea.
SD-OCT easier for paediatric cases
SD-OCT is easier to use when obtaining measurements in children, compared to time-domain OCT, claims a recent study in the British Journal of Ophthalmology.
SLT in glaucoma management
A good alternative treatment option for reducing IOP
Patterned laser trabeculoplasty
Study demonstrates safety of PLT and its potential to treat open angle glaucoma
Gamma-irradiated cornea allograft is effective for glaucoma surgery
Gamma-irradiated cornea allograft is safe and effect for use in glaucoma surgery, according to a paper published in the latest issue of the Journal of Glaucoma.
Glaucoma research grants awarded
The International Glaucoma Association (IGA) will be awarding five grants totaling ?255 000 for critical glaucoma research.
Stepladder technique successful for malignant glaucoma
Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.
Combined scleral buckle and BGI is effective
Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting glaucoma and retinal detachment.
POAG surgical outcomes affected by DM
According to recently published data, POAG patients with diabetes mellitus (DM) undergoing primary trabeculectomy with MMC do not achieve the same long-term IOP control compared to patients without DM.
Pressure-sensitive lens tolerable and safe for 24 hours
A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy subjects and glaucoma sufferers.
Trabectome alternative for glaucoma surgery
Trabectome, a device that ablates the arc of trabecular meshwork, is a safe and effective alternative to glaucoma surgery, according to a recent paper.
Fixed combinations in POAG and OHT patients
An overview of trials comparing topical medical therapies
Monitoring glaucoma progression with SLP
SLP has excellent reproducibility and may be useful in monitoring glaucoma progression.
EyeTechCare secures third round of funding for EyeOP1
EyeTechCare has secured ?10 million in a third round of funding for two international clinical trials for the EyeOP1 glaucoma treatment.
POAG detection successful with tract-based spatial imaging
Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.
High patient satisfaction for ocular hypotensives
Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims a recent investigation.
Beclomethasone nasal spray doesn't increase IOP
Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary open-angle glaucoma, reveals a study in the Journal of Glaucoma.
Ivantis completion of financing novel glaucoma procedure
Ivantis announced the completion of financing $27 million for a novel glaucoma procedure at the Glaucoma Research Foundation's latest meeting.
Adherence to glaucoma medication higher in the mornings
Patient adherence to glaucoma medication could increase with morning application of glaucoma medication.
Corneal thickness affects glaucoma severity
Thinner corneas could be linked to higher glaucoma severity.
Severe FECD increases risk of glaucoma and OHT
Severe Fuchs endothelial corneal dystrophy (FECD) increases the risk of developing glaucoma and/or ocular hypertension (G/OHT).
Axial length affects RNFL thickness profiles
Axial length/refractive status affects the peripapillary retinal nerve fibre layer (RNFL) thickness profile in eyes measured by RTVue OCT.